In this double-blind trial , we randomly assigned etonogestrel implant users reporting @ consecutive days or more of bothersome bleeding to receive @ pills of study drug ( @ microgram levonorgestrel and @ microgram ethinyl estradiol combined OCPs ) or an identical-appearing placebo .